Clinical Trial Update: A Phase II Clinical Trial to Study the Efficacy and Safety of a New Drug P276-00 in Treatment of Recurrent and/or Locally Advanced Head and Neck Cancer [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase II trial evaluating the efficacy and safety of P276-00 in recurrent and/or locally advanced head and neck squamo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• P276-00 (P276-00)

Snippet

Sponsor: Piramal Enterprises Limited | Conditions: Squamous Cell Carcinoma of Head and Neck | Phase 2 | Status: COMPLETED